SBIR/STTR Reauthorization
SBIR/STTR Reauthorization: Navigating the Changes
The SBIR/STTR landscape is shifting, and these changes directly impact how startups secure non-dilutive funding. Join Dr. Nao Gamo and us for a focused online session that breaks down the latest reauthorization updates, from new disclosure and compliance requirements to rising expectations around commercialization.
You’ll learn what’s changed, how it impacts your application strategy, and what founders must do to stay competitive. If SBIR/STTR funding is part of your roadmap, this session will help you navigate the new terrain with confidence.
Femtech that Scales
Femtech that Scales: Innovation, Evidence and Adoption
In this panel, three CEOs share perspectives across the full startup lifecycle, from early concept and product development to scaling and real-world adoption.
Watch now to gain practical insights into the challenges, strategies, and opportunities involved in developing, validating, and bringing healthcare technologies to market within today’s rapidly evolving MedTech landscape.
Archived Panel Discussions
AI in MedTech
Navigating the FDA Maze
De-Risking MedTech Product Development: From Idea to FDA
Product Market Fit: Align Your Product, Strategy, and Commercialization
IP strategies for Protecting MedTech Innovations in the Digital Age
IP strategies for Protecting MedTech Innovations in the Digital Age
Navigating Clinical Trials: Critical Strategies for MedTech Success
Non-Dilutive Funding for MedTech Innovators - SBIRs and Beyond
From Pitch to Investment: MedTech Fundraising Strategies That Work

Amplify MedTech’s webinar gave us practical insights on reimbursement and payer engagement—truly impactful for our MedTech journey.
DataPorium





